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Background: Racial disparities in kidney transplantation in children have been found in the United States,
but have not been studied before in Europe.
Study Design: Cohort study.
Setting & Participants: Data were derived from the ESPN/ERA-EDTA Registry, an international pediatric
renal registry collecting data from 36 European countries. This analysis included 1,134 young patients
(aged #19 years) from 8 medium- to high-income countries who initiated renal replacement therapy (RRT)
in 2006 to 2012.
Factor: Racial background.
Outcomes & Measurements: Differences between racial groups in access to kidney transplantation,
transplant survival, and overall survival on RRT were examined using Cox regression analysis while adjusting 
for age at RRT initiation, sex, and country of residence.
Results: 868 (76.5%) patients were white; 59 (5.2%), black; 116 (10.2%), Asian; and 91 (8.0%), from other 
racial groups. After a median follow-up of 2.8 (range, 0.1-3.0) years, we found that black (HR, 0.49; 95% CI, 
0.34-0.72) and Asian (HR, 0.54; 95% CI, 0.41-0.71) patients were less likely to receive a kidney transplant than 
white patients. These disparities persisted after adjustment for primary renal disease. Transplant survival rates 
were similar across racial groups. Asian patients had higher overall mortality risk on RRT compared with white 
patients (HR, 2.50; 95% CI, 1.14-5.49). Adjustment for primary kidney disease reduced the effect of Asian 
background, suggesting that part of the association may be explained by differences in the underlying 
kidney disease between racial groups.
Limitations: No data for socioeconomic status, blood group, and HLA profile.
Conclusions: We believe this is the first study examining racial differences in access to and outcomes of 
kidney transplantation in a large European population. We found important differences with less favorable 
outcomes for black and Asian patients. Further research is required to address the barriers to optimal treat-
ment among racial minority groups.
INDEX WORDS: Children; adolescents; pediatric; health policy; renal replacement therapy (RRT); kidney 
transplantation; renal disease; racial disparities; health disparity; ethnic minority; immigrant; Europe.In developed countries, end-stage renal disease(ESRD) affects 5 to 10 children per million age-
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of life, and lower costs compared to long-term dialysis
therapy.1-3 Health care providers therefore aim for
kidney transplantation as early as possible and only
initiate patients on dialysis therapy as a bridging
treatment if circumstances require postponement of
transplantation. However, concern has arisen regar-
ding racial disparities in access to transplantation,
especially based on studies conducted in the adult
chronic kidney failure population.4-6 In the United
States, black patients have lower access to and poorer
outcomes of kidney transplantation than their white
counterparts.7 White patients are far more likely to
receive a preemptive kidney transplant and are less
likely to receive dialysis for more than 3 years before
transplantation.8
Few studies have examined racial disparities in
children with ESRD. Results of studies conducted in
the United States and Canada parallel those performed
in adult patients, with black children and adolescents
having reduced access to deceased donor wait-listing9
and lower rates of preemptive and living donor
transplantations compared with white children.10-12 A
study performed in the Netherlands and Belgium
found that children, adolescents, and young adults of
non-Western origin were more often treated with
hemodialysis instead of peritoneal dialysis and had
decreased access to kidney transplantation compared
with children, adolescents, and young adults of
Western origin.13,14 However, although the total
number of non-Western immigrants in Europe is
growing,15 information for other European countries
is lacking. We therefore aimed to assess differences
in: (1) access to kidney transplantation, (2) transplant
survival, and (3) overall patient survival on RRT
between racial groups among children, adolescents,
and young adults on RRT in Europe.
METHODS
Patients
Data were derived from the registry of the European Society
of Pediatric Nephrology and the European Renal Association2
European Dialysis and Transplant Association (ESPN/ERA-
EDTA). On an annual basis, the ESPN/ERA-EDTA Registry
collects individual patient data for date of birth, sex, treatment
modality at initiation of RRT, and subsequent modality changes of
all young individuals requiring RRT by renal registries from 36
European countries. Twenty-two of these registries supply data for
racial background. For the present study, we included data for
patients 19 years or younger who initiated RRT in 2006 to 2012. To
avoid confounding by economic factors in the association between
race and outcomes, the analysis was restricted to medium- and
high-income countries. We included countries with a gross do-
mestic product per capita based on purchasing power parity higher
than the median value for all European countries providing data for
racial background (ie, US $17,140). Data for purchasing power
parity were derived from the databases of the World
Bank Database.16 Furthermore, we only included countries with
racial variation (ie, .1 racial group) in their patient population.As a result, data from the following countries and periods were
available and included in the analysis: Belgium (2006-2011),
Czech Republic (2007-2012), Greece (2006-2012), the
Netherlands (2006-2012), Portugal (2007-2012), Slovakia
(2007-2012), Switzerland (2010-2012), and the United Kingdom
(2006-2012).
Because this study is based on anonymized registry data, neither
ethics committee approval nor informed consent from the included
patients was required.
Definitions
Racial background was categorized as white, black, Asian, and
other. The group Asian consisted of the subcategories South-East
Asian and North-East Asian, while the group “other” included the
subcategories Arabic-Middle East, North African, and mixed. In-
formation for race was reported to the national registries by the
renal units.
Patient age at initiation of RRT was categorized into 4 groups:
0 to 1, 2 to 5, 6 to 10, and 11 to 19 years. Kidney diseases were
grouped by primary renal disease codes for children according to
the ERA-EDTA Registry coding system adapted for children.17
Furthermore, we defined focal segmental glomerulosclerosis,
membranoproliferative glomerulonephritis type I and II, primary
hyperoxaluria, and hemolytic uremic syndrome as primary renal
diseases with a high risk for disease recurrence after kidney
transplantation.18
Statistical Analysis
To explore differences in demographic and clinical character-
istics between racial groups, we used c2 test for categorical anal-
ysis and one-way analysis of variance for continuous variables.
Access to transplantation in the first 3 years after initiating RRT
was analyzed based on the time between the initiation of RRT and
the date of kidney transplantation. In case of preemptive trans-
plantation, this time was set on 1 day. Follow-up time was censored
at patient death, loss to follow-up, or the end of the study period
(December 31, 2012), whichever came first. When studying access
to living donor transplantation, deceased donor transplantation,
transplantation with an unknown type of donor, and death can be
considered as competing events because they can influence the
chance of receiving a kidney from a living donor.19,20 We therefore
applied the cumulative-incidence competing-risks method to study
this outcome. As sensitivity analysis, we repeated this analysis
including only patients 2 years and older because countries or
centers may have different policies with regard to transplantation in
children younger than 2 years. Five-year transplant survival after
receiving a kidney transplant was calculated using the time between
date of kidney transplantation and date of transplant failure (marked
by retransplantation or return to dialysis therapy). Follow-up time
was censored at patient death, loss to follow-up, or the end of the
study period, whichever came first.
Finally, Kaplan-Meier analysis was performed to assess overall
5-year patient survival on RRT. Patient survival was defined as the
time between initiation of RRT and date of death. Follow-up time
was censored at loss to follow-up or end of the study period.
Cox proportional hazards analysis was performed to examine
the associations between race and time from initiation of RRT to
first transplantation, transplant survival, and overall patient sur-
vival on RRT, all while adjusting for potential confounders.21 As
described, competing events were present when analyzing this
association and a cause-specific approach was used to calculate
hazard ratios (HRs).19,20 In the primary analyses, we did not adjust
for primary renal disease because when racial background is
considered as a biological factor, primary renal disease may be in
the causal pathway in the association between racial background
and the outcomes studied. In this case, it does not fulfil the criteria
for confounding.21 However, additional analyses were performed
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mary renal disease. Therefore, the variable “primary renal disease”
was added to the multivariate model for analysis of patient sur-
vival, and the variable “primary renal disease with a high risk of
recurrence,” to the multivariate models for analysis of access to
transplantation and transplant failure. Finally, we repeated the
analysis for patient survival and access to transplantation using a
frailty model with the variable country as a random effect in the
Cox proportional hazard model.
Results are presented as HRs with 95% confidence intervals
(CIs). All analyses were performed using SPSS, version 20.0 (SPSS
Inc). A 2-tailed P5 0.05 was considered as statistically significant.
RESULTS
Patients
Data for racial background were available for 1,134
of the 1,468 (77.2%) patients. Baseline characteristicsTable 1. Demographic and Clinical Cha
All
(N 5 1,134)
White
(n 5 868 [76.
Age at RRT initiation
0-1 y 181 (16.0) 146 (16.8
2-5 y 167 (14.7) 128 (14.7
6-10 y 241 (21.3) 179 (20.6
11-19 y 545 (48.1) 415 (47.8
Male sex 694 (61.2) 541 (62.3
Country of residencea
Belgium 108 (9.5) 74 (8.5)
Czech Republic 38 (3.4) 37 (4.3)
Greece 64 (5.6) 54 (6.2)
Netherlands 149 (13.1) 120 (13.8
Portugal 113 (10.0) 92 (10.6
Slovakia 23 (2.0) 16 (1.8)
Switzerland 31 (2.7) 28 (3.2)
United Kingdom 608 (53.6) 447 (51.5
Primary renal diseasea
CAKUT 461 (40.7) 373 (43.0
Glomerulonephritis 133 (11.7) 92 (10.6
Cystic kidney disease 110 (9.7) 87 (10.0
Hereditary nephropathy 83 (7.3) 67 (7.7)
Ischemic kidney failure 27 (2.4) 19 (2.2)
HUS 39 (3.4) 33 (3.8)
Metabolic disorder 35 (3.1) 28 (3.2)
Vasculitis 15 (1.3) 12 (1.4)
Miscellaneous 89 (7.8) 76 (8.5)
Unknown/missing 142 (12.5) 81 (9.3)
Primary renal disease with high
risk for recurrencea,b
127 (12.2) 91 (11.6
Initial RRT modality
Peritoneal dialysis 492 (43.4) 385 (44.4
Hemodialysis 320 (28.2) 228 (26.3
Transplantation 292 (25.7) 237 (27.3
Missing/unknown 30 (2.6) 18 (2.1)
Follow up time, y 2.80 [1.18-4.82] 2.85 [1.23-4
Note: Values for categorical variables are given as number (perce
Abbreviations: CAKUT, congenital anomalies of the kidney and
replacement therapy.
aStatistically significant different across racial groups (P, 0.05).
bFocal segmental glomerulosclerosis, membranoproliferative glomof the 1,134 included patients are summarized in
Table 1. The majority of patients were white (n5 868
[76.5%]), 59 (5.2%) were black, 116 (10.2%) were
Asian, and 91 (8.0%) were from other racial groups.
The last group consisted of 14 (15%) patients with an
Arabic-Middle East background, 13 patients (14%)
from North Africa, and 64 patients (70%) from mixed
racial backgrounds. The distribution of country of
residence was significantly different across racial
groups (P , 0.001), especially among Asian patients,
of whom 95.7% were from the United Kingdom.
Black patients were more likely to have glomerulo-
nephritis compared with white patients and patients
from other racial backgrounds, who were more likely
to have congenital anomalies of the kidney andracteristics of Patients (2006-2012)
5%])
Black
(n 5 59 [5.2%])
Asian
(n 5 116 [10.2%])
Other
(n 5 91 [8.0%])
) 4 (7) 14 (12.1) 17 (19)
) 10 (17) 17 (14.7) 12 (13)
) 15 (25) 23 (19.8) 24 (26)
) 30 (51) 62 (53.4) 38 (42)
) 32 (54) 67 (57.8) 54 (59)
0 (0) 0 (0) 34 (3)
0 (0) 1 (0.9) 0 (0)
0 (0) 1 (0.9) 9 (10)
) 15 (25) 3 (2.6) 11 (12)
) 20 (34) 0 (0) 1 (1)
0 (0) 0 (0) 7 (8)
2 (3) 0 (0) 1 (1)
) 22 (37) 111 (95.7) 28 (31)
) 17 (29) 34 (29.3) 37 (41)
) 17 (29) 13 (11.2) 11 (12)
) 3 (5) 13 (11.2) 7 (8)
2 (3) 8 (6.9) 6 (7)
2 (3) 1 (0.9) 5 (6)
2 (3) 1 (0.9) 3 (3)
0 (0) 5 (4.3) 2 (2)
2 (3) 1 (0.9) 0 (0)
5 (9) 4 (3.4) 4 (4)
9 (15) 36 (31.0) 16 (18)
) 16 (32) 12 (15.0) 8 (9)
) 23 (39) 45 (38.8) 39 (43)
) 26 (44) 35 (30.2) 31 (34)
) 10 (17) 26 (22.4) 19 (21)
0 (0) 10 (8.6) 2 (2)
.83] 2.83 [1.08-4.49] 1.91 [0.85-4.62] 2.50 [1.33-5.20]
ntage); for continuous variables, as median [interquartile range].
urinary tract; HUS, hemolytic uremic syndrome; RRT, renal
erulonephritis type I and II, primary hyperoxaluria, and HUS.
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emptive transplantation was nominally more common
in white patients, differences between racial groups
were not statistically significant (P 5 0.06). Median
follow-up ranged from 1.91 (interquartile range, 0.85-
4.65) years in Asian patients to 2.85 (interquartile
range, 1.23-4.83) years in black patients, but these
differences were not statistically significant (P 5 0.3).
Data for racial background were missing for 334
patients. Baseline characteristics for patients with
and without data for racial background were signif-
icantly different regarding country of residence
(P , 0.001; Table S1, available as online supple-
mentary material).
Access to Transplantation
The median time from initiation of RRT until
receiving the first kidney transplant was significantly
longer in black, Asian, and other patients (25.1, 23.5,
and 19.4 months, respectively) compared with white
patients (12.5 months, log-rank test P 5 0.002). When
we excluded preemptive transplantations, this differ-
ence was still present (20.2 months in white patients
vs 35.2, 27.5, and 25.5 months in black, Asian, and
other patients, respectively; log-rank test P 5 0.01).
A competing-risks approach was used to calculate
unadjusted cumulative incidences of kidney trans-
plantation in the first 3 years after the initiation ofoNksirtastneitapfo.oN
No. of patients at risk No. 
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Figure 1. (A-D) Cumulative incidence of receiving a kidney transp
(RRT).RRT for the different racial groups, as shown in
Fig 1A to D. After 3 years, 77% of white patients
and 79% of other patients had received a first trans-
plant compared with 64% of black patients and 63%
of Asian patients. Three years after the initiation of
RRT, the proportion of patients living with a kidney
from a living donor was 31% in white patients, 19%
in black patients, 16% in Asian patients, and 18% in
the group of other racial backgrounds.
To assess the association between racial back-
ground and time between initiation of RRT to first
kidney transplant, a Cox proportional hazards model
was used (Table 2). After adjusting for potential
confounders, including age at initiation of RRT, sex,
and country, both black and Asian patients were less
likely than white patients to receive a first kidney
transplant in the first 3 years after initiating RRT
(HRs of 0.49 [95% CI, 0.34-0.72] and 0.54 [95% CI,
0.41-0.71], respectively). The association between
race and access to transplantation, irrespective of
differences in primary renal disease, was investigated
by additional adjustment for primary renal disease
with high risk for recurrence. This yielded very
similar HRs, indicating that differences in the under-
lying cause of kidney disease do not explain the
differences in access to kidney transplantation across
racial groups. In addition, we repeated the Cox
regression analyses for access to transplantation usingksirtastneitapfo.
of patients at risk
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Table 2. HRs for Access to Transplantation in the First 3 Years After the Initiation of RRT, by Racial Group
Unadjusted HR (95% CI) P Adjusted HRa (95% CI) P Adjusted HRb (95% CI) P
White, n 5 868 1.00 (reference) 1.00 (reference) 1.00 (reference)
Black, n 5 59 0.64 (0.44-0.92) 0.02 0.49 (0.34-0.72) ,0.001 0.56 (0.38-0.84) 0.004
Asian, n 5 116 0.69 (0.52-0.90) 0.007 0.54 (0.41-0.71) ,0.001 0.54 (0.40-0.73) ,0.001
Other, n5 91 0.83 (0.63-1.09) 0.2 0.92 (0.69-1.23) 0.6 0.93 (0.68-1.27) 0.9
Abbreviations: CI, confidence interval; HR, hazard ratio; RRT, renal replacement therapy.
aModel I: adjusted for age at RRT initiation (category), sex, and country.
bModel II: adjusted for age at RRT initiation (category), sex, country, and primary renal disease with high risk for recurrence (focal
segmental glomerulosclerosis, membranoproliferative glomerulonephritis type I and II, primary hyperoxaluria, and hemolytic uremic
syndrome).
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Figure 2. Kaplan-Meier curves for 5-year patient survival by
racial group. Abbreviation: RRT, renal replacement therapy.
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effect. This analysis yielded similar results and did 
not change our conclusions.
Because countries or centers may have different 
policies with regard to transplantation in very young 
children, we performed sensitivity analyses including 
only patients 2 years and older. Excluding the youn-
gest patients yielded higher unadjusted transplantation 
rates of 84% and 83% in white and other patients, 
respectively, compared with 71% in black patients 
and 70% in Asian patients. Results from the adjusted 
Cox regression analysis for access to transplantation 
were very similar to those for the total patient group 
(Table S2).
Transplant Survival
A total of 775 patients received a transplant in the 
first 5 years after the initiation of RRT. In total, 48 
transplant failures occurred, of which 19 (40%) were 
from a deceased donor and 5 (10%) were from a 
living donor. For the other 24 transplant failures, 
donor source was unknown. The 5-year probability of 
transplant survival was similar among racial groups, 
varying from 85.0% in Asian patients to 93.0% in the 
groups of patients with other racial backgrounds. Also 
after adjustment for age at the initiation of RRT, sex, 
country, and primary renal disease with high risk for 
recurrence, transplant survival rates ware similar.
Patient Survival on RRT
Patient survival probability at 5 years after the 
initiation of RRT was 95.9% (95% CI, 94.5%-
96.9%). In total, 47 patients died (36 were white; 1, 
black; 9, Asian; and 1, other). Twenty eight (60%) of 
them had initiated RRT before the age of 5 years, 45 
(96%) had initiated RRT with dialysis (peritoneal 
dialysis, n 5 26 [58%]), and only 7 had received a 
kidney transplant during their course of RRT (2 with a 
living donor kidney transplant). Causes of death 
included infections (n 5 13 [28%]), cardiovascular 
diseases (n 5 7 [15%]), withdrawal from treatment 
(n 5 5 [11%]), malignancy (n 5 1 [2%]), and 
miscellaneous causes (n 5 18 [38%]). Cause of death 
was missing or unknown in 3 (6.4%) cases.Kaplan-Meier analysis (Fig 2) and unadjusted Cox
regression analysis (Table 3) showed higher mortality
risk for Asian patients compared with their white
counterparts. After adjustment for age at initiation of
RRT, sex, and country, the mortality risk was 2.5-fold
higher for Asian patients than for white patients (HR,
2.50; 95% CI, 1.14-5.49). The effect of race was
partially taken away by additional adjustment for
primary renal disease, suggesting that the association
of racial background with mortality may be partially
mediated by the underlying kidney disease (Table 3).
Repeating the Cox regression analyses for patient
survival using a frailty model with the variable
country as a random effect yielded similar results and
did not change our conclusions.
DISCUSSION
This large European study of children, adolescents,
and young adults with ESRD showed that black and
Asian patients were about half as likely to receive a
kidney transplant as white patients, a finding that was
not explained by differences in cause of kidney fail-
ure. Transplant survival rates across different racial
groups were similar, but Asian patients had a 2.5-fold
higher risk for death than white patients, which was
partly explained by a difference in primary renal
disease distribution.
Table 3. HRs for Mortality in the First 5 Years After the Initiation of RRT, by Racial Group
Unadjusted HR (95% CI) P Adjusted HRa (95% CI) P Adjusted HRb (95% CI) P
White, n 5 868 1.00 (reference) 1.00 (reference) 1.00 (reference)
Black, n 5 59 0.41 (0.06-2.99) 0.4 0.80 (0.11-6.09) 0.8 0.53 (0.07-4.16) 0.6
Asian, n 5 116 2.08 (1.00-4.32) 0.05 2.50 (1.14-5.49) 0.02 1.86 (0.83-4.18) 0.1
Other, n5 91 0.26 (0.04-1.91) 0.2 0.28 (0.04-2.13) 0.2 0.26 (0.03-1.98) 0.2
Abbreviations: CI, confidence interval; HR, hazard ratio; RRT, renal replacement therapy.
aModel I: adjusted for age at RRT initiation (category), sex, and country.
bModel II: adjusted for age at RRT initiation (category), sex, country, and primary renal disease.
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kidney transplantation for black and Asian patients
are in line with those of previous studies. In a study of
the incidence of living and deceased donor trans-
plantation in US Renal Data System (USRDS) data
among children, adolescents, and young adults with
ESRD, black and Hispanic patients had lower access
to both deceased and living preemptive kidney
transplantation compared with white patients, even
after adjusting for individual- and neighborhood-level
measures of socioeconomic status.22,23 Furthermore,
Furth et al9 studied access to the kidney waiting list
for black and white patients aged 0-19 years using the
USRDS database. They showed that at any time
point, black patients were significantly less likely than
white patients to be activated on this waiting list.
Similar disparities have been found in countries with
universal access to health care, such as for indigenous
children in Canada, Australia, and New Zea-
land10,24,25 and immigrant children, adolescents, and
young adults in the Netherlands and Belgium.26
The causes of the observed disparities in kidney
transplantation in children are thought to be multi-
factorial and are likely to be influenced by a complex
mixture of biological, socioeconomic, and cultural
factors. Because we observed a significantly higher
incidence of primary renal disease known to be
associated with high risk for disease recurrence (and
subsequent transplant loss) in black patients, we hy-
pothesized that this might partly explain the differ-
ence in access to transplantation. However, when we
adjusted for this category of primary renal disease, the
HRs did not change. This means that primary renal
disease does not explain the differences in access to
kidney transplantation and that additional possibly
nonbiological factors are involved.
With regard to living kidney donation, it has been
suggested that family members from minority groups
may be less likely to be medically suitable as donors
due to an increased prevalence of obesity, diabetes, and
hypertension in these groups.27,28 Furthermore, part of
the difference could be due to differences in patients’
opinions regarding transplantation. A Dutch study
looking into the willingness of accepting living donor
kidney transplantation among 160 adult patients withESRD recently identified other nonmedical factors
leading to reduced living related donation, and hence
longer dialysis time, among minority groups. Those
factors included different beliefs and attitudes toward
donation as a result of insufficient knowledge and
communication within their social network, but also
misunderstandings and miscommunication between
patients and their families.29 Finally, the variability in
nephrologists’ opinions and their preferences regarding
medical, psychosocial, and behavioral considerations
might partially account for the disparity in access to
kidney transplantation, as might patients’ sociodemo-
graphic and education status.30 For example, a patient’s
racial background may influence the physician’s
thoughts concerning the patient’s behaviors and like-
lihood of treatment success.31
We found similar transplant survival rates across
the different racial groups, which is in line with
findings from studies conducted in the French and
Canadian adult RRT population. These also reported
similar transplant survival rates between patients of
African descent and their white counterparts.32,33
However, studies including children, adolescents,
and young adults with ESRD from the United States
showed differences in transplant failure rates between
racial groups. Chavers et al34 evaluated 13,692 US
patients aged ,19 years with a functioning kidney
transplant in 1980 to 2004. After adjusting for mul-
tiple covariates, the transplant failure rate among
African Americans was about 2-fold higher than for
white patients during the entire study period. It has
been suggested that this difference between the
United States and other countries could be explained
by a lack of universal access to health care in the
United States, particularly to immunosuppressive
drug coverage. However, a more recent study con-
ducted in the United States found that even after
adjusting for poverty level and insurance status,
transplant survival rates were worse among black
recipients compared with white patients.35
In terms of mortality risk on RRT, we found that
Asian patients had a more than 2 times higher mortality
risk compared with white patients. Adjustment for
primary renal disease reduced the effect of racial
background, suggesting that part of this effect may be
Published in final edited form as: Am J Kidney Dis. 2016 Feb;67(2):293-301. doi: 10.1053/j.ajkd.2015.09.023explained by differences in the underlying kidney dis-
ease between racial groups. This is in line with data 
from a large study from the United States of 23,401 
children and adolescents with ESRD, which also found 
primary renal disease to be independently associated 
with mortality risk.36 Our findings are in contrast to 
results from a recent study conducted in New Zea-
land.25 That study found high survival rates in Asian 
children on RRT, even comparable to their European 
counterparts. However, the study included too few 
Asian patients (n 5 12) for meaningful subanalysis.
Asian patients spent a longer period on dialysis 
treatment due to the reduced access to (living) kidney 
transplantation, which may have led to a higher risk 
for death.1,2 Based on this theory, we had expected 
higher mortality risk in black patients as well. How-
ever, in contrast to data from the United States,36 we 
did not find statistically significantly different mor-
tality rates between white and black patients. 
Possibly, the relatively low mortality rates reported 
among black dialysis patients compared with their 
white counterparts in the adult ESRD population are 
also present among children with ESRD.37
Our study has several strengths, including the 
involvement of many countries in Europe, relatively 
long follow-up, and the distinction of 4 different 
racial groups. In addition, we used a competing-risk 
approach for the analysis of access to transplan-
tation from a living kidney donor to take into account 
the influence of competing events (ie, transplantation 
from a deceased donor and death). However, there 
are also some limitations. First, the number of 
patients from minority groups in our study was 
relatively small and unequally distributed across 
countries. We attempted to adjust for these in-
equalities by correcting for country of residence in 
multivariate analyses. Second, data for racial back-
ground were missing for 22.8% of patients, which, 
given the differences found between outcomes of 
patients with and without data for racial background, 
may induce selection bias. To further investigate the 
identified disparities, the collection of data about 
racial background and socioeconomic status should 
therefore be strongly encouraged in registries. In 
addition, because we only included data from me-
dium- and high-income countries, our results might 
not be generalizable to all European countries. Also, 
because data for racial background were reported by 
the renal units, we cannot exclude differences in 
coding systems for racial background used by na-
tional renal registries. Finally, although our registry 
includes a comprehensive set of clinical parameters, 
information for blood group and HLA profiles and 
data for socioeconomic status were not available for a 
sufficient number of patients. As a result, we were not 
able to disentangle biological effects other thanprimary renal disease (eg, blood group and genotype)
from socioeconomic aspects of racial background.
In conclusion, we found important differences in
access to transplantation and overall mortality on RRT
among children, adolescents, and young adults with
ESRD in Europe, with less favorable outcomes for
black and Asian patients. Known biological aspects of
racial background such as primary renal disease
explained this disparity only partially, making it likely
that other biological and socioenvironmental aspects
are involved. The complex interactions between
biological and socioenvironmental factors should be
better studied to direct the targeted interventions so
that this disparity can be reduced across racial sub-
groups. Although some racial disparities, such as
mismatches with deceased donor kidneys and type of
kidney diseases, may be unavoidable, interventions
that improve preemptive and living donor trans-
plantation are called for, especially in racial minority
groups. In addition, further research is required to
identify and address the contribution of medical and
sociocultural barriers to preferred treatment among
these groups.
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